Bioactive Substances and Skin Health: The Role of Pharmacy and Nutrition—Properties and Technology

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".

Deadline for manuscript submissions: 27 September 2024 | Viewed by 1736

Special Issue Editors


E-Mail Website
Guest Editor
Municipal Health and Consumer Unit, Guadix City Council (Granada), School of Health Sciences, Valencia International University, Valencia, Spain
Interests: bioethics; parenteral nutrition; health education; pharmacy
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmacy and Pharmaceutical Technology, University of Granada, Granada, Spain
Interests: pharmacy, pharmaceutical technology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Nutrition and Bromatology of the University of Granada, Granada, Spain
Interests: antioxidants; parenteral nutrition; nutrients; food

Special Issue Information

Dear Colleagues,

Bioactive substances can have therapeutic potential, including the prevention and/or treatment of a disease. The diversity of the chemical structures of bioactive compounds influences their bioavailability and biologic properties. In fact, it has been shown that bioactive substances can provide benefits to the skin, such as increased hydration, reduction in wrinkles, and improvements in elasticity, density, and skin texture, along with antioxidant and anti-inflammatory actions induced via UV radiation, reduction in the signs of dermatitis, and prevention against some forms of skin cancer. Pharmaceutical and nutritional sciences can join forces to provide a variety of bioactive substances that play an important role in skin health.

This Special Issue aimed to present the advances and studies available on how bioactive substances can be a useful option for skin health.

Dr. Francisco Rivas
Dr. Margarita López-Viota
Dr. Rafael Giménez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • supplements
  • bioactive substances
  • skin health

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 2584 KiB  
Article
Antibacterial, Anti-Biofilm, and Anti-Inflammatory Properties of Gelatin–Chitosan–Moringa-Biopolymer-Based Wound Dressings towards Staphylococcus aureus and Escherichia coli
by Salma Bessalah, Asim Faraz, Mohamed Dbara, Touhami Khorcheni, Mohamed Hammadi, Daniel Jesuwenu Ajose and Shamsaldeen Ibrahim Saeed
Pharmaceuticals 2024, 17(5), 545; https://doi.org/10.3390/ph17050545 - 23 Apr 2024
Viewed by 1367
Abstract
In contemporary times, the sustained aspiration of bioengineering and biomedical applications is the progressive advancement of materials characterized by biocompatibility and biodegradability. The investigation of the potential applications of polymers as natural and non-hazardous materials has placed significant emphasis on their physicochemical properties. [...] Read more.
In contemporary times, the sustained aspiration of bioengineering and biomedical applications is the progressive advancement of materials characterized by biocompatibility and biodegradability. The investigation of the potential applications of polymers as natural and non-hazardous materials has placed significant emphasis on their physicochemical properties. Thus, this study was designed to investigate the potential of gelatin–chitosan–moringa leaf extract (G–CH–M) as a novel biomaterial for biomedical applications. The wound-dressing G–CH–M biopolymer was synthesized and characterized. The blood haemolysis, anti-inflammatory, antioxidant, and antibacterial activities of the biopolymer were investigated against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial isolates. Our results showed that S. aureus swarming motility was drastically affected. However, the biopolymer had no significant effect on the swarming motility of E. coli. In addition, the biopolymer showed high antibacterial capacities, especially against S. aureus. Plasmid DNA was observed to be effectively protected from oxidative stresses by the biopolymer. Furthermore, the biopolymer exhibited greatly suppressed haemolysis (lower than 2%), notwithstanding the elevated concentration of 50 mg/mL. These results indicated that this novel biopolymer formulation could be further developed for wound care and contamination prevention. Full article
Show Figures

Figure 1

Back to TopTop